Marshall Wace North America L.P. bought a new position in HealthSouth Corporation (NYSE:HLS) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 136,288 shares of the company’s stock, valued at approximately $5,860,000.
A number of other institutional investors have also modified their holdings of the company. Bayesian Capital Management LP boosted its position in shares of HealthSouth Corporation by 93.2% in the fourth quarter. Bayesian Capital Management LP now owns 19,698 shares of the company’s stock worth $812,000 after buying an additional 9,500 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of HealthSouth Corporation by 17.7% in the fourth quarter. Renaissance Technologies LLC now owns 386,900 shares of the company’s stock worth $15,956,000 after buying an additional 58,200 shares in the last quarter. Sawgrass Asset Management LLC acquired a new position in shares of HealthSouth Corporation during the first quarter worth about $324,000. State of Alaska Department of Revenue acquired a new position in shares of HealthSouth Corporation during the first quarter worth about $235,000. Finally, Russell Investments Group Ltd. acquired a new position in shares of HealthSouth Corporation during the fourth quarter worth about $5,266,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HealthSouth Corporation (NYSE:HLS) traded down 1.00% during midday trading on Thursday, hitting $47.35. 225,933 shares of the company’s stock traded hands. The company has a 50 day moving average price of $46.52 and a 200 day moving average price of $42.93. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $47.89. The firm has a market capitalization of $4.24 billion, a price-to-earnings ratio of 17.68 and a beta of 0.75.
HealthSouth Corporation (NYSE:HLS) last announced its earnings results on Thursday, April 27th. The company reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.05. HealthSouth Corporation had a net margin of 6.80% and a return on equity of 28.73%. The company had revenue of $974.80 million during the quarter, compared to the consensus estimate of $960.05 million. During the same period in the previous year, the firm posted $0.61 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. Equities analysts anticipate that HealthSouth Corporation will post $2.70 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, July 17th. Shareholders of record on Monday, July 3rd will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date is Thursday, June 29th. HealthSouth Corporation’s dividend payout ratio is presently 35.96%.
WARNING: This news story was published by sleekmoney and is the sole property of of sleekmoney. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://sleekmoney.com/marshall-wace-north-america-l-p-takes-position-in-healthsouth-corporation-hls/1912364.html.
Several brokerages have commented on HLS. Royal Bank Of Canada raised their price target on shares of HealthSouth Corporation from $48.00 to $50.00 and gave the company an “outperform” rating in a research note on Monday, February 27th. Stephens upgraded shares of HealthSouth Corporation from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, February 22nd. Mizuho raised their price target on shares of HealthSouth Corporation from $38.00 to $44.50 and gave the company a “neutral” rating in a research note on Wednesday, February 22nd. Zacks Investment Research lowered shares of HealthSouth Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, April 25th. Finally, ValuEngine lowered shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $47.79.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/marshall-wace-north-america-l-p-takes-position-in-healthsouth-corporation-hls/1912364.html
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.